文献速递脊柱脊髓外科

退变性腰椎管狭窄症中长期自然史及临床恶化预测因素

Mid- to long-term natural history of degenerative lumbar spinal stenosis and predictors for clinical deterioration.
PubMed 文献 · J Neurosurg Spine · 2025-09-12

本研究回顾性分析202例症状性腰椎管狭窄症患者,随访≥5年,平均随访121个月,19.3%出现临床恶化。多因素分析显示发育性腰椎管狭窄是恶化危险因素(p=0.031),硬膜囊面积增大为保护因素(p=0.045),硬膜囊面积<55 mm²预测5年内恶化AUC为0.781。

要点

  • 症状性腰椎管狭窄症中长期随访约19.3%出现临床恶化。
  • 发育性腰椎管狭窄是恶化独立危险因素,硬膜囊面积增大为保护因素。
  • 硬膜囊面积<55 mm²对5年内临床恶化有较好预测价值。

核心结论

  • 多数症状性腰椎管狭窄伴神经源性跛行患者中长期保持行走能力,未出现运动或括约肌功能障碍。
  • 无发育性狭窄及硬膜囊面积未严重减小时,保守治疗是可选择方案。

研究设计与样本

  • 回顾性队列研究,纳入202例症状性腰椎管狭窄症成人患者,随访≥5年,平均随访121±40个月。
  • 临床恶化定义为肌节性下肢无力、括约肌障碍或神经源性跛行致行走耐受≤10分钟中至少一项。

主要发现

  • 39例(19.3%)出现临床恶化,其中36例(92.3%)行走耐受下降,8例(20.5%)肌节性无力,2例(5.1%)括约肌障碍。
  • 多因素分析显示发育性腰椎管狭窄是恶化危险因素(p=0.031,调整HR=10.11),硬膜囊面积增大为保护因素(p=0.045,调整HR=0.98)。
  • 硬膜囊面积<55 mm²预测症状出现后5年内临床恶化AUC为0.781。

关键数值与推荐

  • 临床恶化定义:肌节性下肢无力、括约肌障碍或神经源性跛行致行走耐受≤10分钟。
  • 发育性腰椎管狭窄为恶化危险因素(p=0.031),硬膜囊面积增大为保护因素(p=0.045)。
  • 硬膜囊面积<55 mm²预测5年内恶化AUC=0.781。

临床怎么用

  • 对症状可耐受且功能期望较低、无发育性狭窄及硬膜囊面积未严重减小的患者,可考虑保守治疗。
  • 硬膜囊面积<55 mm²者应警惕5年内临床恶化风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Mid- to long-term data on the natural history of degenerative lumbar spinal stenosis (LSS) remain limited as surgery is increasingly favored. The aim of this study was to characterize the prevalence of clinical deterioration over long-term follow-up and to identify risk and protective factors. METHODS: In this retrospective cohort study, adult patients with symptomatic LSS and a follow-up period ≥ 5 years were analyzed. Clinical deterioration was defined by at least one of the following factors: myotomal lower limb weakness, sphincter disturbance, or a decrease in walking tolerance to ≤ 10 minutes due to neurogenic claudication. Radiological assessment included standing lumbar radiographs and lumbosacral MR images obtained after symptom onset. A univariate analysis was performed, with variables demonstrating significance levels of p < 0.1 included in the subsequent multivariable logistic regression analysis. Receiver operating characteristic (ROC) curves and Kaplan-Meier survival curves were plotted for statistically significant risk factors. RESULTS: A total of 202 patients with symptomatic LSS and adequate follow-up were included. The mean age was 65.2 ± 4.2 years at the onset of neurological symptoms and the mean follow-up duration was 121 ± 40 months. Clinical deterioration occurred in 39 patients (19.3%). Among those with deterioration, 36 (92.3%) reported reduced walking tolerance due to neurogenic claudication, 8 (20.5%) had myotomal weakness, and 2 (5.1%) experienced sphincter disturbance. Upon multivariate analysis, the presence of lumbar developmental spinal stenosis was a risk factor for deterioration (p = 0.031), while an increased dural sac area was protective (p = 0.045); adjusted hazard ratios were 10.11 and 0.98, respectively. A dural sac area < 55 mm2 had an area under the ROC curve of 0.781 for predicting clinical deterioration within 5 years of symptom onset. CONCLUSIONS: Patients with lumbar stenosis and neurogenic claudication mostly remained ambulatory without developing motor deficits or sphincter dysfunction. Conservative management is an option for patients with tolerable symptomatology and low functional expectations, especially in the absence of the identified risk factors of developmental narrowing of lumbar canal dimensions and critically reduced dural sac area over the most stenotic level.

来源:J Neurosurg Spine,查看原文。版权归原作者所有。

引用

  1. Ng SY, Wong JS, Wang G, et al. Mid- to long-term natural history of degenerative lumbar spinal stenosis and predictors for clinical deterioration. J Neurosurg Spine. 2025. PMID: 40939213. doi:10.3171/2025.5.SPINE25215

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。